CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 8-K Event Material agreement · New debt or obligation
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Open-market sale Director sold 13,093 shares at $5.86 ($76,669)
- 4 Open-market sale Chief Executive Officer sold 69,420 shares at $5.86 ($406,503)
- 4 Open-market sale Chief Financial Officer sold 25,411 shares at $5.86 ($148,799)
- 4 Planned sale Director sold 5,176 shares at $5.82 ($30,147)
- 4 Open-market sale Director sold 10,738 shares at $5.86 ($62,879)
- 4 Open-market sale SVP, Chief Legal Officer sold 17,428 shares at $5.86 ($102,053)
- 4 Open-market sale Director sold 13,093 shares at $5.86 ($76,669)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Acquisition or sale completed · Results of operations · Other events
- 4 Grant or award Chief Financial Officer acquired 13,333 shares (grant or award)
- 4 Open-market sale Chief Financial Officer sold 17,795 shares at $6.76 ($120,294)
- 4 Open-market sale Chief Executive Officer sold 50,676 shares at $6.76 ($342,570)
Page 8 of 66 · 1,318 filings